DE   EN   ES   FR   IT   PT


Inosine

Препарат Рибоксин. ОАО "Биохимик" Республика Мордовия


Producer: JSC Biokhimik Republic of Mordovia

Code of automatic telephone exchange: C01EB

Release form: Liquid dosage forms. Solution for infusions.

Indications to use: Coronary heart disease. Arrhythmia. Myocardial dystrophy. Liver diseases. Hepatitis. Fatty degeneration of a liver. Cirrhosis.


General characteristics. Structure:

Active ingredient: 20 mg of inosine (inosine).

Excipients: hexamethylenetetramine (methenamin), solution of natron caustic (sodium hydroxide), water for injections.

Drug kazyvat anti-hypoxemic and antiarrhytmic action. Increases power balance of a myocardium, improves coronary circulation, prevents effects of intraoperative ischemia of kidneys.




Pharmacological properties:

Pharmacodynamics. Inosine - derivative (nucleoside) of purine - the predecessor of adenosinetriphosphate (ATP). Treats group of the medicines stimulating metabolic processes. Has anti-hypoxemic and antiarrhytmic effect. Increases power balance of a myocardium, improves coronary circulation, prevents effects of intraoperative ischemia of kidneys. Is directly involved in exchange of glucose and promotes activation of exchange in the conditions of a hypoxia and in the absence of ATP.

Activates metabolism of pyruvic acid necessary for ensuring normal process of tissue respiration, and also promotes activation of a xanthinedehydrogenase. Stimulates synthesis of nucleotides, increases activity of some enzymes of a tricarbonic acid cycle. Getting into cells, has positive effect on processes of metabolism in a myocardium - increases force of reductions of heart and promotes fuller relaxation of a myocardium in a diastole therefore the stroke output increases. The mechanism of antiarrhytmic action is up to the end not clear. Reduces aggregation of thrombocytes, activates an angenesis (especially a myocardium and a mucous membrane of a GIT).

Pharmacokinetics. It is metabolized in a liver with formation of glucuronic acid and the subsequent its oxidation. In insignificant quantity it is allocated with urine.


Indications to use:

Complex treatment of the postponed myocardial infarction, coronary heart disease, the disturbances of a cordial rhythm caused by use of cardiac glycosides; myocardial dystrophies after the postponed infectious diseases. Liver diseases (hepatitises, cirrhosis, fatty dystrophy), urokoproporfiriya. Operations of a pas to the isolated kidney (as means of pharmacological protection at blood circulation switching off).


Route of administration and doses:

Drug is used intravenously struyno slowly or kapelno (40-60 drops 1 minute). Treatment begin with introduction 200 mg (10 ml of 2% of solution) once a day, then, at good tolerance, the dose is increased to 400 mg (20 ml of 2% of solution) by 1-2 times a day. Duration of treatment is 10-15 days.

Jet administration of drug is possible at acute disorders of a heart rhythm in a single dose of 200-400 mg (10-20 ml of 2% of solution). For pharmacological protection of the kidneys subjected to ischemia, inosine is entered intravenously struyno in a single dose of 1,2 g (60 ml of 2% of solution) in 5-15 minutes prior to crossclamping of a renal artery, and then by 0,8 more g (40 ml of 2% of solution) immediately after blood circulation recovery.

At drop introduction to a vein of 2% solution of drug is dissolved in 5% solution of a dextrose (glucose) or 0,9% chloride sodium solution (to 250 ml).



Side effects:

Allergic reactions: a skin itch, a dermahemia (drug should be cancelled). Seldom: increase in concentration of uric acid in blood, an exacerbation of gout (at prolonged use).



Contraindications:

Hypersensitivity to drug, gout, a hyperuricemia, pregnancy, the lactation period, age up to 18 years (efficiency and safety are not established). With care to apply at a renal failure.



Storage conditions:

In the dry, protected from light place at a temperature from 20-25 °C. In the place, unavailable to children. Period of validity 3 years. Not to use after the expiry date specified on packaging.


Issue conditions:

According to the recipe


Packaging:

Solution for intravenous administration of 20 mg/ml. 5 ml in ampoules of neutral glass. 5 ampoules in a blister strip packaging from a PVC film. 2 planimetric packagings place in a pack from a cardboard. 10 ampoules place in a pack from a cardboard with partitions or lattices, or a separator from a cardboard or paper bag. 10 ampoules place in a box from a cardboard. Put the application instruction and a knife in each pack or a box ampoule or the scarificator ampoule. When using ampoules with notches, rings of a break or points of a break the knife ampoule or the scarificator ampoule is not put.



Similar drugs

Препарат Рибоксин. ОАО "Биохимик" Республика Мордовия

Inosine

Metabolic means.



Препарат Рибоксин. ОАО "Биохимик" Республика Мордовия

Inosine

The means influencing the alimentary system and metabolic processes.





  • Сайт детского здоровья